Innovation Rules at ARPA-E Energy Summit Conference
Researchers Begin Study of IV Iron Treatment for Post-Pregnancy Anemia
November 15, 2022
by Dan McCue
WASHINGTON — Researchers supported by the National Institutes of Health are launching a large-scale study to evaluate a single dose of intravenous iron to treat women experiencing anemia after giving birth.
The study will enroll nearly 5,000 women in Bangladesh, India, Pakistan, the Democratic Republic of Congo, Kenya, Zambia and Guatemala.
It will be conducted by researchers in the Global Network for Women’s and Children’s Health, a group of clinical sites funded by the NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development.
The Foundation for the NIH is providing more than $6 million in funding for the study, with contributions from a grant from the Bill and Melinda Gates Foundation.
Participants will be randomized to receive either a single dose of intravenous iron solution between six- and 48-hours after giving birth or a six-week supply of oral iron supplements. According to the standard of care, both groups also will receive the vitamin folate in the infusion or as tablets.
Iron deficiency anemia increases sharply among individuals after birth, resulting in fatigue, weakness, shortness of breath, reduced cognitive abilities, depression and other symptoms. Anemia may also compromise a mother’s ability to provide care for her baby.
Previous studies have found intravenous iron to be effective at preventing anemia in pregnancy, but it has not been studied as a treatment for anemia after pregnancy. Researchers will compare the prevalence of mild anemia, iron levels, depression scores, quality of life scores and other measures between the two groups to assess the treatment’s effectiveness.
Dan can be reached at dan@thewellnews.com and at https://twitter.com/DanMcCue
In The News
Health
Voting
Research
March 23, 2023
by Dan McCue
Innovation Rules at ARPA-E Energy Summit Conference
NATIONAL HARBOR, Md. — It’s not a conference so much as a dream factory that’s transpiring through Friday on the... Read More
NATIONAL HARBOR, Md. — It’s not a conference so much as a dream factory that’s transpiring through Friday on the shores of the Potomac River. Now in its 13th year, the ARPA-E Innovation Summit is a three-day program of lectures, networking events and exhibition hall displays... Read More
March 6, 2023
by Dan McCue
NIH Successfully Tests Temperature-Stable TB Vaccine
WASHINGTON — A temperature-stable, experimental tuberculosis vaccine has been found safe and effective in a clinical phase 1 trial involving... Read More
WASHINGTON — A temperature-stable, experimental tuberculosis vaccine has been found safe and effective in a clinical phase 1 trial involving healthy adults conducted by the National Institute of Allergy and Infectious Diseases. A non-temperature stable form of the candidate previously had been tested in several clinical... Read More
February 28, 2023
by For Man Behind Gene-Edited Babies, a Rocky Return to Science
For Man Behind Gene-Edited Babies, a Rocky Return to Science
Five years ago, scientist He Jiankui shocked his peers and the world with claims that he created the first genetically edited... Read More
Five years ago, scientist He Jiankui shocked his peers and the world with claims that he created the first genetically edited babies. Now, after serving three years in a Chinese prison for practicing medicine without a license, he faces obstacles and critics as he tries to re-enter... Read More
February 21, 2023
by Dan McCue
Spinal Cord Stimulation May Restore Arm and Hand Mobility After Stroke
WASHINGTON — Researchers using a device that stimulates the spinal cord said they successfully restored hand mobility in two stroke... Read More
WASHINGTON — Researchers using a device that stimulates the spinal cord said they successfully restored hand mobility in two stroke patients, allowing them to perform daily life activities like using a fork to eat a meal.While the study was admittedly small — it involved only two... Read More
February 15, 2023
by Dan McCue
NIH Evaluating Antiviral in Adults Hospitalized With COVID-19
WASHINGTON — The National Institutes of Health has begun a multi-state clinical trial evaluating an “investigational antiviral” for the treatment... Read More
WASHINGTON — The National Institutes of Health has begun a multi-state clinical trial evaluating an “investigational antiviral” for the treatment of adults hospitalized with COVID-19. The treatment, known as S-217622 or ensitrelvir fumaric acid, was developed in Japan by Hokkaido University and Shionogi & Co., Ltd.... Read More
February 13, 2023
by Dan McCue
Blending Hydrogen With Natural Gas Could Help Energy Transition
EDMONTON, Canada — Burning a blend of hydrogen and natural gas to heat homes could reduce carbon emissions by as... Read More
EDMONTON, Canada — Burning a blend of hydrogen and natural gas to heat homes could reduce carbon emissions by as much as 5% per year without having to change existing infrastructure, according to a report out of the University of Alberta. The blended fuel, called hythane,... Read More
News From The Well
